Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial.
Wick A, Sander A, Koch M, Bendszus M, Combs S, Haut T, Dormann A, Walter S, Pertz M, Merkle-Lock J, Selkrig N, Limprecht R, Baumann L, Kieser M, Sahm F, Schlegel U, Winkler F, Platten M, Wick W, Kessler T.
Wick A, et al. Among authors: pertz m.
BMC Cancer. 2022 Jun 13;22(1):645. doi: 10.1186/s12885-022-09720-z.
BMC Cancer. 2022.
PMID: 35692047
Free PMC article.
Clinical Trial.